Clearly these studies demonstrate that HV-68 infected mice harboring metastatic breast cancer had no significant increases in the numbers of CD11b+Gr-1+ MDSCs in vivo at 44 days post-breast cancer transplantation. The gene discussed is ITGAM; the disease is breast carcinoma.